Puig in the news

Puig is undervalued despite strong growth in APAC and potential for significant upside through M&A, though risks include APAC demand slowdown and regulatory exposure.

Puig is acquiring the remaining 50% stake in dermocosmetic firm Isdin from Esteve for 1.2 billion euros to expand its dermoesthetics presence.

Puig is acquiring full ownership of dermocosmetics brand Isdin for 1.2 billion euros from Corporación Químico-Farmacéutica Esteve to expand its presence in the skin care market.

Puig's Ana Trias discusses the increasing convergence of fashion and beauty, the company's unique approach to managing its diverse portfolio, and strategic plans for brand development and retail expansion.

Puig's president of brands, José Manuel Albesa, details his philosophy on the future of beauty, personal style, and his approach to well-being and inspiration.

Puig Brands' stock is rising, surpassing resistance and activating a bullish target of approximately 18.51€ per share.

Estée Lauder faces 100 new lawsuits over asbestos-contaminated talcum powder, adding to existing cases, while the company defends its product safety.

Estée Lauder achieved a 156 million euro net profit and 5% revenue increase in its last fiscal year, recovering from previous losses and growing across divisions despite failed merger talks with Puig.

Estée Lauder's stock jumped after beating quarterly earnings estimates, ending a streak of revenue declines, and confirming job cuts while a potential merger with Puig was suspended.

This article analyzes five Spanish stocks—Solaria, Fluidra, Cellnex, IAG, and Puig—with significant growth potential, contrasting them with Repsol and Indra, which have already seen substantial gains.

Puig's recovery in the stock market has stalled, despite earlier positive analyst recommendations, with technical experts indicating a need to overcome key resistance for sustained growth.

Charlotte Tilbury launches its 2026 beauty advent calendar, featuring 15 products, early access for app members, and a £170 price.

Puig's stock recovery has stalled despite analyst upgrades, facing renewed market doubts and a significant decline since its IPO.

Alphavalue summarizes Puig Brand SA as having solid delivery but limited visibility, with full article access requiring a MarketScreener subscription.

The Ibex 35 reached new highs, closing above 20,000 points, with significant contributions from Indra and Puig amid geopolitical developments and mixed company news.

Goldman Sachs has added Puig to its "Directors’ Cut" list, highlighting its strong investment potential with a price target of 21.5 euros per share due to its growth in beauty and fashion products and strong financial results.

Berenberg updated its estimates and raised its price target for Puig Brands to 18.10 euros, maintaining a 'hold' recommendation, after the company's Q2 results exceeded expectations due to strong sales and new product launches.